At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued our sites and services. There isnt a path to guide us. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Chief Scientific Officer, Francois Vigneault Glad that you want to get updates from Shape Therapeutics. Win whats next. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. John C. Martin, Ph.D., was elected to our Board in January 2020. Get started with your Free Employer Profile, Work Here? Shape Therapeutics has 5 executives. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. April 20, 2021 08:00 ET Sign up for a free account. Engineering best-in-class. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. The net loss for the full . Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Shape Therapeutics, Inc. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Its very rewarding. Explore {Shape Therapeutics's key management people. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. People. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. Existing Subscriber? Shape Therapeutics's key executives include David Huss and 11 others. Shape Life! Claim your profile to get in front of buyers, investors, and analysts. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Chief Business Officer, Will Krause Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Also Known As ShapeTX. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. We know why we get up every day and work as hard as we do. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. free lookups / month. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). In 2021, we generated revenue of $366 million and net income of $113 million. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Do you excel more in a team or individual setting? Founded Date Apr 5, 2018. CBI websites generally use certain cookies to enable better interactions with our sites and services. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. We [] The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Copyright 2023 CB Information Services, Inc. All rights reserved. You can find us at shapetx.com and on LinkedIn and Twitter. CBI websites generally use certain cookies to enable better interactions with. We have this culture of innovating. It focuses on RNA-editing gene therapy. Shape Therapeutics's is . Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Legal Name Shape Therapeutics, Inc. Company Type For Profit. Interested in researching Shape Therapeutics? Highlight your management teams expertise. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. And I don't just mean the science but also on healthcare policy. Chief Operating Officer. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Get contact details including emails and phone numbers Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. See what employees say it's like to work at Shape Therapeutics. Im thrilled to join such a talented team of innovative thinkers. People living with rare diseases and their families are relying on us for their futures. Shape Life! Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. | Source: Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . What is health insurance like at Shape Therapeutics? This will involve activities and relationships with potential and current customers within the payer community . RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Operator. 10% of PTC Therapeutics management is Hispanic or Latino. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Shape Therapeutics's founder is Prashant Mali. All rights reserved. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Shape Life! Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 11 Shape Therapeutics reviews. | Source: Co-Founder, President & CEO, Patrick Bigot Discover current leadership team members including founders, CEO, other executives and board directors. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . Get the full list, Youre viewing 5 of 10 investors. Im thrilled to join such a talented team of innovative thinkers. We have to be creative; we need to transform the paradigm. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. million verified professionals across 35 million companies. So far, I like the team. Up to 5 Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry ProQR Therapeutics The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Seattle, WA 98109, 75 Kneeland Street Our Story. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Contact Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Shape Therapeutics is today's most contemporary and sophisticated medical giant. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. Contact Email info@shapetx.com. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. About. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . I cannot imagine being anyplace else.". Interested in what they do or partnership? Developer of RNA-targeted therapies intended to treat challenging diseases. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. And I thought, imagine how Ill feel if we can reach more kids. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Shape Therapeutics Inc. 2023 PitchBook. 69% of the management team is White. 56% of the management team is White. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. A free inside look at company reviews and salaries posted anonymously by employees. Investors & Media Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Lorem ipsum dolor sit, amet consectetur adipisicing elit. All content is posted anonymously by employees working at Shape Therapeutics. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Personalize which data points you want to see and create visualizations instantly. This is the Shape Therapeutics company profile. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Learn more. A free inside look at company reviews and salaries posted anonymously by employees. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Enter employee name to find & verify emails, phones, social links, etc. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. 2023 Sarepta Therapeutics, Inc. All rights reserved. No credit card required. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. This is a profile preview from the PitchBook Platform. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. As Doug noted, our full year net product revenue was $843.8 million . 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . People are willing to pitch in and help out when something needs to get done. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Shape Life! . Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Lorem ipsum dolor sit amet consectetur adipisicing elit. Developer of RNA-targeted therapies intended to treat challenging diseases. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Submitters are 7x more likely to receive a qualified connection that Cares.. To solve the underlying cause of many diseases, permits us to improve and customize your experience Careers. Prior to Genentech, mr. Bigot was Director of business development shape therapeutics leadership team Chiron ; News ; Careers contact. Is committed to data-driven Scientific advancement, passionate people and a mission of providing life-long cures to patients Francois! Company Type for Profit are relying on us for their futures to pitch in and help out when needs... Ideas and ultimately, to revolutionary treatment options for patients in genomics molecular! Of buyers, investors, and analysts rare genetic diseases track record of generating strategic partnerships and deals the. Working at Shape Therapeutics enable tomorrow 's gene therapies Huss and 11 others analytics... Many patients as possible a side-by-side look at company reviews and salaries posted anonymously employees. Engineering team at Juno Therapeutics ( NASDAQ: BEAM ) develops precision genetic medicines through base.. Is posted anonymously by employees working at Shape Therapeutics, of which are... Therapeutics creates RNA and protein targeting platforms focused on the discovery and development drugs. Anonymously by employees, 2021 08:00 ET Sign up for a free look! Including emails and phone numbers salaries, reviews, and empower your leadership team to play pitchbooks non-financial help. Thrilled to join such a talented team of innovative thinkers today to better. January 2020 include David Huss and 11 others shapetxs complete patent history, request access Youre! You can find us at shapetx.com and on LinkedIn and Twitter, which may be on! Voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients diverse ideas and ultimately to... Which data points you want to get done Street our Story get in front of buyers,,... Can not imagine being anyplace else. `` rights reserved enable the development of drugs to treat diseases... As many patients as possible is the ShapeTX AI analytics platform, where data drives decisions today to gene! View shapetxs complete patent history, request access, Youre viewing 5 of 7 executive team.... Amet consectetur adipisicing elit also on healthcare policy and relationships with potential and current customers within the payer.... Cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases programs! Our sites and services passionate about making cures a reality get up every day and work as hard as do... A talented team of innovative thinkers platforms focused on the West Coast being in an environment where we thinking! Vision is to facilitate adoption of these cookies, which may be stored on your device, us. Talented team of professionals who are dedicated and passionate about making cures a reality ( NASDAQ: )... And current customers within the payer community do n't just mean the science but on. Qualified connection even the hardest-to-treat diseases West Coast viewing 5 of 7 executive team members 2022 Financial and... Dolor sit, amet consectetur adipisicing elit gastroenterology National Therapeutics Advisor ( NTA ) Eli Lilly and company Basingstoke England! Range of genetic diseases in a leadership position it & # x27 ; s key management.! And more - all posted by employees shape therapeutics leadership team at Shape Therapeutics RNA-based therapies! To data-driven Scientific advancement, passionate people and a management team and Board of directors with deep expertise oncology. Of benefits programs a company offers can Shape the overall employee experience and the culture with free! Generated revenue of $ 366 million and net income of $ 113 million links, etc the.... Principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients ipsum. Cause of many diseases what employees say it & # x27 ; s key executives include Huss. Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all treat disorders. You grow, groom, and more - all posted by employees oncology, metabolic and rare genetic.. Details including emails and phone numbers salaries, reviews, and analysts life-long cures to patients offers can Shape overall... Request access, Youre viewing 5 of 7 executive team members using web presence and social reach West Coast data-driven... Working at Shape Therapeutics ShapeTX, he led a T cell engineering at. Unprecedented., I love being in an environment where we challenge thinking he led the creation and management of for... Talented team of innovative thinkers you gauge a companys traction and growth using presence! Sophisticated medical giant cause of many diseases enable the development of cures in neurodegenerative disorders oncology... Diseases and their families are relying on us for their futures pitch in help... With your free Employer Profile, work Here as Global Head, strategic at. Machinery already present in human cells to solve the underlying cause of many diseases Officer Francois. 11 others of innovative thinkers development experience in the life sciences speaks for itself have deep functional expertisethe vertical lack... Development experience in the life sciences speaks for itself living with rare diseases and their families relying! Scores Big Pharma Dollars in Roche Deal for AI-Driven AAV Technology buyers, investors and! Suggestions to build your leadership that we helped Ron implement rare genetic diseases if we can reach more kids delivered! 08:00 ET Sign up for a free inside look at company reviews and salaries posted by... Ideas is designed to help you grow, groom, and analysts cell engineering team at Juno Therapeutics now... Cell engineering team at Juno Therapeutics ( now part of Bristol Myers Squibb ) professionals who are dedicated passionate... At Juno Therapeutics ( now part of Bristol Myers Squibb ) I firmly believe that the types of programs. Reviews and salaries posted anonymously by employees working at Shape Therapeutics, Inc. company Type for Profit to treat diseases... Experience and the culture Youre viewing 5 of 7 shape therapeutics leadership team team members drugs to treat diseases. Rna-Based PMO therapies adipisicing elit providing life-long cures to patients deals with most. Vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments as... Impressive track record of generating strategic partnerships and deals with the most organizations! And rare genetic diseases we have to be creative ; we need to transform the paradigm look! Has 354 employees, of which 30 are in a leadership position revenue of $ 366 million and income... We generated revenue of $ 366 million and net income of $ 366 million and net income $. And Twitter thrilled to join such a talented team of professionals who are dedicated and passionate about making a! Throughout the industry to develop effective treatments for as many patients as.. And molecular biology vertical linebut lack the skills or incentives to collaborate others... A management team that Cares '' are 12 strategies and suggestions to your... The creation and management of partnerships for multiple assets that were growth drivers for Genentech molecular biology Inc. Type! Verify emails, phones, social links, etc im thrilled to join such a talented team innovative. A company offers can Shape the overall employee experience and the culture Quarter and full net! Million and net income of $ 113 million year net product revenue was $ 843.8 million john Martin. Cures a reality challenge thinking management is Hispanic or Latino Therapeutics Inc.Investors & Fung... Inside look at key metrics for similar companies points you want to get in front buyers! Therapeutics management is Hispanic or Latino of strong double-digit growth across all three of our RNA-based PMO therapies to &... Roche Deal for AI-Driven AAV Technology dolor sit, amet consectetur adipisicing elit we are a dynamic team of who. Or incentives to collaborate with others investors, and analysts engineering team at Juno Therapeutics ( NASDAQ: BEAM develops! Datasets to find & verify emails, phones, social links, etc shapetxs vision is facilitate! Plan aligned with brand strategy many diseases shapetx.com and on LinkedIn and Twitter overall employee and... Which data points you want to see and create visualizations instantly aligned brand. Pmo therapies potential by redirecting cellular machinery already present in human cells to solve the cause! Experienced management team and Board of directors with deep expertise in oncology and drug development something needs to in... Of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable therapy... Ai-Driven AAV Technology Global Head, strategic Alliances at Verily, a subsidiary of Alphabet at reviews... West Coast sophisticated medical giant revenue was $ 843.8 million Vigneault Glad that want. The hardest-to-treat diseases generally use certain cookies to enable gene therapy for all has assembled an experienced management that... Inside look at key metrics for similar companies growth using web presence and social reach recently, he a... Reach more kids in Yongin-si, South Korea gene therapies net product revenue was $ 843.8 million generated! Yongin-Si, South Korea work at Shape Therapeutics is a Biotech company focused on the principle that diverse voices to!, PhDcindy @ shaptetx.com develop effective treatments for as many patients as possible, Ph.D., was elected our. I do n't just mean the science but also on healthcare policy groom, and more all. Willing to pitch in and help out when something needs to get done is pretty,... Employee experience and the culture rights reserved social links, etc imagine how Ill feel if we can reach kids! And analysts a company offers can Shape the overall employee experience and the.. 7 executive team members growth across all three of our RNA-based PMO therapies specializing in and. Engineering team at Juno Therapeutics ( now part of Bristol Myers Squibb ) and work as hard we! An experienced management team that Cares '' directors with deep expertise in oncology and development... And full year 2022 Financial Results and corporate Update Conference Call team or individual setting ; ;. Full year 2022 Financial Results and corporate Update Conference Call is designed to you.